Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034825 · ClinicalTrials.gov registry record
Multi-site Decision Impact Study for Decipher
A clinical trial, sponsored by GenomeDx Biosciences.
- Completed
- Registry status
- 50
- Enrollment target
NCT02034825: Completed study, sponsored by GenomeDx Biosciences.
NCT02034825 is a clinical trial that has completed, run by GenomeDx Biosciences. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02034825 has completed, sponsored by GenomeDx Biosciences.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This prospectively designed retrospective clinical utility study will evaluate urologists' treatment recommendations before and after reviewing Decipher results for selected patient cases.
Interventions
- OTHER Decipher Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02034825
The ClinicalTrials.gov registry entry for NCT02034825 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GenomeDx Biosciences, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decipher Questionnaire is the first listed.
NCT02034825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02034825 about?
NCT02034825 is a clinical study titled "Multi-site Decision Impact Study for Decipher". This prospectively designed retrospective clinical utility study will evaluate urologists' treatment recommendations before and after reviewing Decipher results for selected patient cases.
What is the current status of trial NCT02034825?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02034825?
The interventions under investigation include: Decipher Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02034825?
This trial is sponsored by GenomeDx Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.